Contacts
Alexa Huerta
Investor Relations
Tel 214 937 3190
alexahuerta@orthofix.com
Denise Landry
Media Relations
Tel 214 937 2529
deniselandry@orthofix.com
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will host an Analyst Teach-In Meeting in Lewisville, TX on Monday, March 13, 2023 from 2:30 – approximately 6:30 p.m. CT.
The event will feature presentations from the C-Suite management team and business unit leaders describing the product portfolio of the newly merged Orthofix-SeaSpine organization, including addressable market opportunity and commercial strategy.
Due to limited capacity, in-person attendance is by invitation only. A live and archived webcast of the event will be available on the Investors page of the company’s website at ir.Orthofix.com.
About the Combined Company:
The newly merged Orthofix-SeaSpine organization is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.
The Company is headquartered in Lewisville, Texas and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and Sao Paulo, Brazil.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230302005830/en/
Related news for (OFIX)
- Orthofix Announces Commercial Partnership with MRIguidance
- Julie Andrews Begins as New Chief Financial Officer at Orthofix
- Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
- Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
- Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis